Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women

References

• Auersperg N, Wong A S, Choi K C, Kang S K, Leung P C. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001; 22: 255–258
   PubMed Web of Science ®Google Scholar
• Pollak M N, Schernhammer E S, Hankinson S E. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004; 4: 505–518
   PubMed Web of Science ®Google Scholar
• Fürstenberger G, Senn H J. Insulin-like growth factors and cancer. Lancet Oncol 2002; 3: 298–302
   PubMed Web of Science ®Google Scholar
• LeRoith D, Roberts C T. The insulin-like growth factor system and cancer. Cancer Lett 2003; 195: 127–137
   PubMed Web of Science ®Google Scholar
• Karasik A, Menczer J, Pariente C, Kanety H. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrinol Metab 1994; 78: 271–276
   PubMed Web of Science ®Google Scholar
• Katsaros D, Yu H, Levesque M A, Danese S, Genta F, Richiardi G, Fracchioli S, Khosravi M J, Diamandi A, Gordini G, et al. IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival. Eur J Cancer 2001; 37: 478–485
   PubMed Web of Science ®Google Scholar
• Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, et al. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 2002; 101: 549–554
   PubMed Web of Science ®Google Scholar
• Stoll B A. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 1999; 53: 83–87
   PubMed Web of Science ®Google Scholar
• Carroll K K. Obesity as a risk factor for certain types of cancer. Lipids 1998; 33: 1055–1059
   PubMed Web of Science ®Google Scholar
• Frost C, Coleman M P. Obesity and ovarian cancer. Eur J Cancer 1997; 33: 1529–1531
   PubMedGoogle Scholar
• Bonora E, Targher G, Alberiche M, Bonadonna R C, Saggiani F, Zenere M B, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subject with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63
   PubMed Web of Science ®Google Scholar
• Stepherd J H. Revised FIGO staging for gynecological cancer. Br J Obstet Gynecol 1989; 96: 889–892
   PubMedGoogle Scholar
• Maculay V M. Insulin like growth factors and cancer. Br J Cancer 1992; 65: 311–320
   PubMedGoogle Scholar
• Holly J M, Gunnell D J, Smith D G. Growth hormone, IGF-1 and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?. J Endocrinol 1999; 162: 21–30
   PubMedGoogle Scholar
• Jones J I, Clemmons D R. Insulin-like growth factors and their binding proteins: biological actions. J Endocr Rev 1995; 16: 3–34
   PubMed Web of Science ®Google Scholar
• Sierra-Honigmann M R, Nath A K, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa W C, Madge L A, Schechner J S, Schwabb M B, Polverini P J, et al. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683–1686
   PubMed Web of Science ®Google Scholar
• Sohda M, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Masuda N, Kuwano H. The role of insulin-like growth factor I and insulin like growth factor binding protein 3 in human esophageal cancer. Anticancer Res 2004; 24: 3029–3034
   PubMed Web of Science ®Google Scholar
• Gregoire Nyomba B L, Johnson M, Berard L, Murphy L J. Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism 1999; 48: 840–844
   PubMed Web of Science ®Google Scholar
• Shah N G, Bhatavdekar J M, Doctor S S, Suthar T P, Balar D B, Dave R S. Circulating epidermal growth factor (IGF-I) in patients with epithelial ovarian carcinoma. Neoplasma 1994; 41: 241–243
   PubMedGoogle Scholar
• Gomez J M, Maravall F J, Gomez N, Navarro M A, Casamitjana R, Soler J. Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin Endocrinol (Oxf) 2003; 58: 213–219
   PubMed Web of Science ®Google Scholar
• Park H Y, Kwon H M, Lim H J. Potetial role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001; 33: 95–102
   PubMed Web of Science ®Google Scholar
• Laud K, Gourdou I, Pessemesse L. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 2002; 188: 219–226
   PubMed Web of Science ®Google Scholar
• Bouloumie A, Drexler H C, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998; 83: 1059–1066
   PubMed Web of Science ®Google Scholar
• Stattin P, Palmqvist R, Soderberg S, Biessy C, Ardnor B, Hallmans G, Kaaks R, Olsson T. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep 2003; 10: 2015–2021
   PubMed Web of Science ®Google Scholar
• Stattin P, Soderberg S, Biessy C, Lenner P, Hallmans G, Kaaks R, Olsson T. Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat 2004; 86: 191–196
   PubMed Web of Science ®Google Scholar
• Dulger H, Alici S, Sekeroglu M R, Erkog R, Ozbek H, Noyan T, Yavuz M. Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer. Int J Clin Pract 2004; 58: 545–549
   PubMedGoogle Scholar
• Lagiou P, Signorello L B, Trichopoulos D, Tzonou A, Trichopoulou A, Mantzoros C S. Leptin in relation to prostate cancer and benign prostatic hyperplasia. Int J Cancer 1998; 76: 25–28
   PubMed Web of Science ®Google Scholar
• Petridou E, Belechri M, Dessypris N, Koukoulomatis P, Diakomanolis E, Spanos E, Trichopoulos D. Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab 2002; 46: 147–151
   PubMedGoogle Scholar
• Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I. Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol 2008; 136: 74–77
   PubMed Web of Science ®Google Scholar
• Lebrecht A, Ludwig E, Huber A, Klein M, Schneeberger C, Tempfer C, Koelbl H, Hefler L. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer. Gynecol Oncol 2002; 85: 32–35
   PubMed Web of Science ®Google Scholar